LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 1235 | 4533 | 4156 | 1.0907 | 1.1290 |
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 1235 | 4753 | 4156 | 1.1436 | 1.2043 |
MCF7 | WH-4-025 | 0.12 | uM | LJP5 | 1 | O11 | 72 | hr | 1235 | 2640 | 4156 | 0.6352 | 0.4809 |
MCF7 | WH-4-025 | 0.12 | uM | LJP5 | 2 | O11 | 72 | hr | 1235 | 2998 | 4156 | 0.7213 | 0.6035 |
MCF7 | WH-4-025 | 0.12 | uM | LJP5 | 3 | O11 | 72 | hr | 1235 | 2725 | 4156 | 0.6557 | 0.5100 |
MCF7 | WZ-4-145 | 0.12 | uM | LJP6 | 1 | J23 | 72 | hr | 1235 | 2909 | 4156 | 0.6999 | 0.5730 |
MCF7 | WZ-4-145 | 0.12 | uM | LJP6 | 2 | J23 | 72 | hr | 1235 | 2712 | 4156 | 0.6525 | 0.5056 |
MCF7 | WZ-4-145 | 0.12 | uM | LJP6 | 3 | J23 | 72 | hr | 1235 | 2958 | 4156 | 0.7117 | 0.5898 |
MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 1 | M11 | 72 | hr | 1235 | 1607 | 4156 | 0.3867 | 0.1272 |
MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 2 | M11 | 72 | hr | 1235 | 1679 | 4156 | 0.4040 | 0.1519 |
MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 3 | M11 | 72 | hr | 1235 | 1634 | 4156 | 0.3932 | 0.1365 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 1235 | 3460 | 4156 | 0.8325 | 0.7617 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 1235 | 3365 | 4156 | 0.8096 | 0.7291 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 1235 | 3683 | 4156 | 0.8862 | 0.8380 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1235 | 2628 | 4156 | 0.6323 | 0.4768 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 2 | H05 | 72 | hr | 1235 | 2682 | 4156 | 0.6453 | 0.4953 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 3 | H05 | 72 | hr | 1235 | 2573 | 4156 | 0.6191 | 0.4580 |
MCF7 | BX-912 | 0.12 | uM | LJP5 | 1 | L23 | 72 | hr | 1235 | 3688 | 4156 | 0.8874 | 0.8397 |
MCF7 | BX-912 | 0.12 | uM | LJP5 | 2 | L23 | 72 | hr | 1235 | 3711 | 4156 | 0.8929 | 0.8476 |
MCF7 | BX-912 | 0.12 | uM | LJP5 | 3 | L23 | 72 | hr | 1235 | 3677 | 4156 | 0.8847 | 0.8360 |
MCF7 | Canertinib | 0.12 | uM | LJP6 | 1 | H11 | 72 | hr | 1235 | 3428 | 4156 | 0.8248 | 0.7507 |
MCF7 | Canertinib | 0.12 | uM | LJP6 | 2 | H11 | 72 | hr | 1235 | 3570 | 4156 | 0.8590 | 0.7993 |
MCF7 | Canertinib | 0.12 | uM | LJP6 | 3 | H11 | 72 | hr | 1235 | 3719 | 4156 | 0.8948 | 0.8503 |
MCF7 | Celastrol | 0.12 | uM | LJP6 | 1 | G11 | 72 | hr | 1235 | 3911 | 4156 | 0.9410 | 0.9161 |
MCF7 | Celastrol | 0.12 | uM | LJP6 | 2 | G11 | 72 | hr | 1235 | 4030 | 4156 | 0.9696 | 0.9568 |